+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cell Targeting"

From
Live Cell Imaging - Global Strategic Business Report - Product Thumbnail Image

Live Cell Imaging - Global Strategic Business Report

  • Report
  • May 2025
  • 189 Pages
  • Global
From
From
From
From
Gene Therapy - Technologies, Markets & Companies - Product Thumbnail Image

Gene Therapy - Technologies, Markets & Companies

  • Report
  • November 2021
  • 802 Pages
  • Global
From
Cell Therapy - Technologies, Markets and Companies - Product Thumbnail Image

Cell Therapy - Technologies, Markets and Companies

  • Report
  • November 2021
  • 1184 Pages
  • Global
From
  • 18 Results (Page 1 of 1)
Loading Indicator

Cell targeting is a biotechnology field that focuses on the development of treatments that target specific cells in the body. It involves the use of drugs, antibodies, and other molecules to target and interact with specific cells. This technology has been used to treat a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. It has also been used to deliver gene therapy and to develop vaccines. Cell targeting is a rapidly growing field, with many companies investing in research and development. Companies are developing new technologies to improve the accuracy and efficiency of cell targeting, as well as to reduce the cost of treatments. These technologies include gene editing, nanotechnology, and artificial intelligence. Some companies in the cell targeting market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more